LEADER 03296nam  22005535  450 
001 9910254272303321
005 20200702172604.0
010   $a3-319-24097-8
024 7 $a10.1007/978-3-319-24097-8
035   $a(CKB)3710000000667106
035   $a(EBL)4528416
035   $a(DE-He213)978-3-319-24097-8
035   $a(MiAaPQ)EBC4528416
035   $a(PPN)194074021
035   $a(EXLCZ)993710000000667106
100   $a20160513d2016      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAnti-Angiogenic Therapy in Ophthalmology /$fedited by Andreas Stahl
205   $a1st ed. 2016.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016.
215   $a1 online resource (198 p.)
225 1 $aEssentials in Ophthalmology,$x1612-3212
300   $aDescription based upon print version of record.
311   $a3-319-24095-1 
320   $aIncludes bibliographical references and index.
327   $aRetinal Vascular Development -- Retinopathy of Prematurity -- Anti-Vascular Endothelial Growth Factor (VEGF) Treatment in Neovascular Age-Related Macular Degeneration: Outcomes and Outcome Predictors -- AREDS Supplementation and the Progression Towards Neovascular Exudative AMD -- VEGF-Inhibition in Macular Telangiectasia Type 2 -- Diabetic Retinopathy -- Retinal Vein Occlusion -- Pharmacokinetics of Intravitreally Applied VEGF Inhibitors -- Neovascular Glaucoma -- Corneal Neovascular Diseases -- Anti?Angiogenic Gene Therapy - Basic Science and Challenges for Translation into the Clinic.
330   $aThis book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases.
410  0$aEssentials in Ophthalmology,$x1612-3212
606   $aOphthalmology
606   $aAngiology
606   $aOphthalmology$3https://scigraph.springernature.com/ontologies/product-market-codes/H44004
606   $aAngiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33010
615  0$aOphthalmology.
615  0$aAngiology.
615 14$aOphthalmology.
615 24$aAngiology.
676   $a617.706
702   $aStahl$b Andreas$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910254272303321
996   $aAnti-Angiogenic Therapy in Ophthalmology$92508601
997   $aUNINA